
Entos Pharmaceuticals
Developing next-generation genetic medicines using their proprietary Fusogenix drug delivery platform.
Employees
Enterprise value
$4—6m
Authorizing premium user...
Developing next-generation genetic medicines using their proprietary Fusogenix drug delivery platform.